Huma continues expansion as Eckuity backs further M&A

UK-headquartered digital health company Huma Therapeutics has acquired US-based remote monitoring firm Aluna and entered a strategic partnership with healthcare growth equity firm Eckuity Capital to support further expansion through M&A. The acquisition of Aluna – also known as Knox Medical Diagnostics – adds respiratory health monitoring capabilities to Huma’s disease-agnostic platform and brings more…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?